logo
Plus   Neg
Share
Email

ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir

ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline PLC(GSK.L,GSK), with Pfizer Inc. and Shionogi Limited as shareholders, announced that it has filed patent infringement litigation against Gilead Sciences Inc. over bictegravir in the United States and Canada. The United States case is filed in the U.S. District Court for the District of Delaware and the patent is U.S patent No. 8,129,385. The Canadian case is filed in the Canadian Federal Court in Toronto.

ViiV Healthcare will seek to prove that Gilead Sciences Inc's triple combination HIV drug containing the HIV integrase inhibitor bictegravir infringes ViiV Healthcare's patent covering ViiV Healthcare's dolutegravir and many other compounds that include dolutegravir's unique chemical scaffold.

ViiV Healthcare will therefore seek financial redress for patent infringement.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Uber Technologies Inc. has appointed Nelson Chai as its new Chief Financial Officer. Chai joins Uber from the Chicago-based Warranty Group, an insurance and warranty provider, where he was CEO. Previously, he spent more than five years at CIT Group, where he most recently served as President. Before... The animals on Barnum's Animals crackers are finally "free," thanks to People for the Ethical Treatment of Animals or PETA. For more than a century, Nabisco's Barnum's Animals crackers have been sold in boxes that depict zebras, lions, gorillas, elephants, and other animals caged in circus boxcars. PETA has forced Nabisco to redesign the packaging of crackers. BHP Billiton plc (BHP.AX, BLT.L, BBL, BHP) reported a profit for the year ended 30 June 2018 that declined 37 percent from last year, reflecting massive write-down on its US onshore oil and gas assets, US tax reform and the ongoing fallout from its Brazilian dam collapse. But, underlying attributable profit increased 33%, supported by 8% Group copper equivalent volume growth.
Follow RTT